Cargando…

Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia

INTRODUCTION: The Sarcopenia Quality of Life (SarQoL(®)) questionnaire was developed to provide a patient-reported outcome measure specific to sarcopenia. Its psychometric properties indicate that it is a valid and reliable instrument. However, until now, its ability to detect change over time has n...

Descripción completa

Detalles Bibliográficos
Autores principales: Geerinck, Anton, Bruyère, Olivier, Locquet, Médéa, Reginster, Jean-Yves, Beaudart, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223987/
https://www.ncbi.nlm.nih.gov/pubmed/30374809
http://dx.doi.org/10.1007/s12325-018-0820-z
_version_ 1783369514569695232
author Geerinck, Anton
Bruyère, Olivier
Locquet, Médéa
Reginster, Jean-Yves
Beaudart, Charlotte
author_facet Geerinck, Anton
Bruyère, Olivier
Locquet, Médéa
Reginster, Jean-Yves
Beaudart, Charlotte
author_sort Geerinck, Anton
collection PubMed
description INTRODUCTION: The Sarcopenia Quality of Life (SarQoL(®)) questionnaire was developed to provide a patient-reported outcome measure specific to sarcopenia. Its psychometric properties indicate that it is a valid and reliable instrument. However, until now, its ability to detect change over time has not been examined. Therefore, the objective of this study is to evaluate the responsiveness (also known as sensitivity to change) of the SarQoL(®) questionnaire in a prospective, longitudinal cohort of community-dwelling, older, sarcopenic subjects. METHODS: Sarcopenic subjects from the SarcoPhAge (Sarcopenia and Physical impairment with advancing Age) study were included. Responsiveness was evaluated with nine pre-specified hypotheses on the correlation between the evolution of the SarQoL(®) scores after a 2-year interval and the evolution of the scores on the Short Form-36 (SF-36) and the Euroqol 5-dimension (EQ-5D) questionnaires. This technique considers responsiveness to be a form of longitudinal validity. Additionally, standardized response means were also calculated to compare the quantity of change measured by the different questionnaires. RESULTS: A total of 42 sarcopenic subjects were included. The median age of the sample was 72.9 (68.9–78.8) years, 59.5% were female, and the mean body mass index was 23.3 (20.4–25.7) kg/m(2). A good responsiveness was observed, as evidenced by the confirmation of eight out of nine hypotheses, well above the 75% confirmation threshold. The standardized response mean of the Overall SarQoL(®) score was significantly higher than those of the SF-36 Physical Component Summary (p = 0.005), the EQ-5D Utility Index (p < 0.001) and the Euroqol visual analogue scale (p = 0.003). CONCLUSION: The first data available on the ability of the SarQoL(®) questionnaire to detect change over time indicates that the questionnaire has good responsiveness. This, together with the previously established psychometric properties, confirms that the SarQoL(®) questionnaire is a relevant instrument for the assessment of quality of life in sarcopenic populations.
format Online
Article
Text
id pubmed-6223987
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-62239872018-11-19 Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia Geerinck, Anton Bruyère, Olivier Locquet, Médéa Reginster, Jean-Yves Beaudart, Charlotte Adv Ther Original Research INTRODUCTION: The Sarcopenia Quality of Life (SarQoL(®)) questionnaire was developed to provide a patient-reported outcome measure specific to sarcopenia. Its psychometric properties indicate that it is a valid and reliable instrument. However, until now, its ability to detect change over time has not been examined. Therefore, the objective of this study is to evaluate the responsiveness (also known as sensitivity to change) of the SarQoL(®) questionnaire in a prospective, longitudinal cohort of community-dwelling, older, sarcopenic subjects. METHODS: Sarcopenic subjects from the SarcoPhAge (Sarcopenia and Physical impairment with advancing Age) study were included. Responsiveness was evaluated with nine pre-specified hypotheses on the correlation between the evolution of the SarQoL(®) scores after a 2-year interval and the evolution of the scores on the Short Form-36 (SF-36) and the Euroqol 5-dimension (EQ-5D) questionnaires. This technique considers responsiveness to be a form of longitudinal validity. Additionally, standardized response means were also calculated to compare the quantity of change measured by the different questionnaires. RESULTS: A total of 42 sarcopenic subjects were included. The median age of the sample was 72.9 (68.9–78.8) years, 59.5% were female, and the mean body mass index was 23.3 (20.4–25.7) kg/m(2). A good responsiveness was observed, as evidenced by the confirmation of eight out of nine hypotheses, well above the 75% confirmation threshold. The standardized response mean of the Overall SarQoL(®) score was significantly higher than those of the SF-36 Physical Component Summary (p = 0.005), the EQ-5D Utility Index (p < 0.001) and the Euroqol visual analogue scale (p = 0.003). CONCLUSION: The first data available on the ability of the SarQoL(®) questionnaire to detect change over time indicates that the questionnaire has good responsiveness. This, together with the previously established psychometric properties, confirms that the SarQoL(®) questionnaire is a relevant instrument for the assessment of quality of life in sarcopenic populations. Springer Healthcare 2018-10-29 2018 /pmc/articles/PMC6223987/ /pubmed/30374809 http://dx.doi.org/10.1007/s12325-018-0820-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Geerinck, Anton
Bruyère, Olivier
Locquet, Médéa
Reginster, Jean-Yves
Beaudart, Charlotte
Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
title Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
title_full Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
title_fullStr Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
title_full_unstemmed Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
title_short Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
title_sort evaluation of the responsiveness of the sarqol(®) questionnaire, a patient-reported outcome measure specific to sarcopenia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223987/
https://www.ncbi.nlm.nih.gov/pubmed/30374809
http://dx.doi.org/10.1007/s12325-018-0820-z
work_keys_str_mv AT geerinckanton evaluationoftheresponsivenessofthesarqolquestionnaireapatientreportedoutcomemeasurespecifictosarcopenia
AT bruyereolivier evaluationoftheresponsivenessofthesarqolquestionnaireapatientreportedoutcomemeasurespecifictosarcopenia
AT locquetmedea evaluationoftheresponsivenessofthesarqolquestionnaireapatientreportedoutcomemeasurespecifictosarcopenia
AT reginsterjeanyves evaluationoftheresponsivenessofthesarqolquestionnaireapatientreportedoutcomemeasurespecifictosarcopenia
AT beaudartcharlotte evaluationoftheresponsivenessofthesarqolquestionnaireapatientreportedoutcomemeasurespecifictosarcopenia